As the clinical signs and symptoms in patients with COL1A1–PDGFB fusion uterine sarcomas in the female genital tract were usually silent in early stages, two out of six patients were initially diagnosed at late stages (IIIB and IVA in cases 2 and 4) as shown in Table 2. The gene discussed is COL1A1; the disease is uterine corpus sarcoma.